McDermott Advises Reproductive Medicine Associates of New Jersey in its Business Combination with The Valencian Infertility Institute of Spain to Create the World’s Largest Fertility Network - McDermott Will & Emery

McDermott Advises Reproductive Medicine Associates of New Jersey in its Business Combination with The Valencian Infertility Institute of Spain to Create the World’s Largest Fertility Network

Overview


MIAMI (April 4, 2017) – International law firm McDermott Will & Emery served as legal adviser to the management division of Reproductive Medicine Associates of New Jersey (RMANJ Management), pioneers in the field of reproductive medicine, in connection with the execution of its business combination with The Valencian Infertility Institute (IVI) of Spain to create a new company called IVI-RMA Global, SL (IVI-RMA Global).

IVI-RMA Global will be the largest global fertility network providing assisted reproduction and related services. IVI-RMA Global and its board of directors, which will be comprised of the founding partners of IVI and RMANJ, will oversee all international business units, including the newly-created IVI America. One of IVI America’s core goals will be to expand the combined company’s footprint in the United States and Canada.

IVI-RMA Global and its affiliated practices will have nearly 2,400 employees across 70 locations around the world, and will include a team of over 200 physicians, and over 300 scientists and researchers. The combination of these platforms will create a unified global entity providing evidence-based fertility solutions that offer patients the greatest chances for success in the shortest time possible.

Founded in 1999, RMANJ became one of the largest and most successful IVF programs in the US. In the last five years, RMANJ has grown nearly 70% in new patients. Last year alone, patients came to RMANJ from over 30 US states and 40 countries.

“The market for healthcare, especially driven by advancing technologies, is becoming more global. This business combination is representative of that trend and will accelerate advances in fertility treatments and services,” said McDermott partner Bernard Grondin who led the McDermott team. “We are enormously pleased to be part of this groundbreaking transaction that will allow these two fertility leaders to collaborate and offer the best possible care to their patients worldwide,” added Dana Dombey, associate at McDermott.

“McDermott’s health care brand, already renowned in the US, has established its reputation in Europe and beyond, largely driven by our regulatory experience in the EU and across the world,” added Stephen Bernstein, global chair of McDermott’s Health Industry Advisory practice. “As more and more of our US-based clients look to grow their businesses abroad, we are able to provide seamless cross-border representation with our international health team that includes health lawyers in the UK and in Germany, and with the strong relationships we have developed with local lawyers in key locations. McDermott has become a go-to firm for healthcare work that does not originate in the US.”

In addition to Miami health care partner Bernard Grondin, the McDermott team representing RMANJ Management included McDermott partners Thomas Young and Carla Hine and associates Dana Dombey and Chelsea Rogers.

Dr. Richard T. Scott, Jr., a founding partner and laboratory director of RMANJ, said “[T]he team at McDermott was instrumental in completing this complex, cross-border transaction and we thank them for their commitment and diligence.”

About the Health Industry Advisory Group at McDermott Will & Emery

McDermott’s lawyers in the United States and Europe, in conjunction with MWE China Law Offices, have successfully negotiated and closed hundreds of deals on behalf of health industry clients worldwide. McDermott’s experienced health care lawyers provide seamless legal counsel that removes the false barriers that often arise between transactional and regulatory issues, moving deals swiftly from negotiation to implementation. Major legal directories have identified McDermott as the undisputed leader in health care law. We are the only firm to receive Tier 1 national rankings by the Legal500 USA, US News – Best Lawyers, and Chambers USA. Combined with the Firm’s ranked private equity practice, this means that funds active in private equity can rely on McDermott for a one-stop legal solution.

About McDermott Will & Emery

McDermott Will & Emery is a premier international law firm with a diversified business practice, with more than 1,000 lawyers and offices in Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, Rome, Seoul, Silicon Valley and Washington, DC. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai

Media Contacts